Commercial Medical Devices

MHRA and NICE Open Evidence Call on Digital Mental Health Technologies Resources

Ivo PetrovNovember 8, 20265 min read0 views

At a glance

  • Responses gathered between 5 November 2026 and 26 February 2027 will be used to judge the Phase 1 outputs of the Wellcome-funded programme and guide its second phase.
  • The MHRA and NICE have opened a call for evidence, running until 26 February 2027, on resources developed under the Wellcome-funded Digital Mental Health Technologies programme. The feedback will be used to assess whether the Phase 1 outputs met their objectives and to inform the direction of Phase 2.
A tablet and smartphone bearing abstract app interface shapes sit on a desk, linked by thin lines of light to a translucent network of nodes representing the groups asked to give feedback.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence on resources produced under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and remains open until 26 February 2027.

The two organisations are seeking views from developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.

What the evaluation covers

According to the MHRA and NICE, the survey forms part of the programme's Phase 1 evaluation. It is intended to establish how the resources have been received and used across the sector, and in particular whether the materials have influenced users' knowledge, confidence, decision-making and professional practice. The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools.

How the findings will be used

Results from the survey will help determine whether the Phase 1 outputs have achieved their intended objectives and will inform the future direction of Phase 2 of the DMHT programme. The organisations say the feedback will help identify strengths, highlight areas for improvement and shape later work aimed at improving the safety and effectiveness of digital mental health technologies.

Stakeholders are encouraged to take part whether they have engaged extensively, minimally or not at all with the existing resources.

Reported by Ivo Petrov, Clinical Laboratory Devices Analyst.